Functional Relevancies of Trans-Differentiation in the Juxtaglomerular Apparatus of Rat Kidney

References

• Razga Z, Nyengaard JR. The effect of angiotensin II on the number of macula densa cells through the AT1 receptor. Nephron Physiol. 2009;112(2):37–43. doi:10.1159/000213507
   Google Scholar
• Ren Y, Garvin JL, Carretero OA. Efferent arteriole tubuloglomerular feedback in the renal nephron. Kidney Int. 2001;59(1):222–229. doi:10.1046/j.1523-1755.2001.00482.x11135074
   PubMed Web of Science ®Google Scholar
• Arendshorst WJ, Brannstrom K, Ruan X. Actions of angiotensin II on the renal microvasculature. J Am Soc Nephrol. 1999;10(Suppl 11):149–161.
   Google Scholar
• Rosivall L, Razga Z, Ormos J. Morphological characterization of human juxtaglomerular apparatus. Kidney Int Suppl. 1991;32:9–12.
   Google Scholar
• Rosivall L, Razga Z, Mirzahosseini S, Tornoci L. Endothelial permeability of the afferent arteriole and its changes as the result of alteration in the activity of the renin-angiotensin system. J Am Soc Nephrol. 1999;10(Suppl 11):172–177.
   Google Scholar
• Razga Z, Nyengaard JR. Estimation of the number of angiotensin II AT1 receptors in rat kidney afferent and efferent arterioles. Anal Quant Cytol Histol. 2007;29(4):208–216.17879628
   PubMed Web of Science ®Google Scholar
• Ichihara A, Hayashi M, Kaneshiro Y, et al. Inhibition of diabetic nephropathy by a decoy peptide corresponding to the “handle” region for nonproteolytic activation of prorenin. J Clin Invest. 2004;114(8):1128–1135. doi:10.1172/JCI2139815489960
   PubMed Web of Science ®Google Scholar
• Ribeiro-Oliveira A Jr., Nogueira AI, Pereira RM, Boas WW, Dos Santos RA, Simoes e Silva AC. The renin-angiotensin system and diabetes: an update. Vasc Health Risk Manag. 2008;4:787–803. doi:10.2147/VHRM.S190519065996
   PubMedGoogle Scholar
• Razga Z, Kovacs G, Bodi N, Talapka P, Nyengaard JR. Heterogeneous downregulation of angiotensin II AT1-A and AT1-B receptors in arterioles in STZ-induced diabetic rat kidneys. Biomed Res Int. 2014;2014:1–6. doi:10.1155/2014/947506
   Web of Science ®Google Scholar
• Osterby R, Bangstad HJ, Nyberg G, Walker JD, Viberti G. A quantitative ultrastructural study of juxtaglomerular arterioles in IDDM patients with micro- and normoalbuminuria. Diabetologia. 1995;38(11):1320–1327. doi:10.1007/BF004017658582542
   PubMed Web of Science ®Google Scholar
• Razga Z, Nyengaard JR. A stereologic approach to estimate the number of immunogold-labeled molecules in cells of tubules. Anal Quant Cytol Histol. 2006;28(1):54–60.16566280
   PubMed Web of Science ®Google Scholar
• Nilius B, Droogmans G. Ion channels and their functional role in vascular endothelium. Physiol Rev. 2001;81(4):1415–1459. doi:10.1152/physrev.2001.81.4.141511581493
   PubMed Web of Science ®Google Scholar
• Razga Z, Kovacs G, Bodi N, Talapka P. Upregulation of the L-type calcium channel in renin-positive smooth muscle cells of arterioles in the kidneys of rats with streptozotocin-induced diabetes. Anal Quant Cytol Histol. 2015;37:214–220.
   Web of Science ®Google Scholar
• Hackenthal E, Metz R, Bührle CP, Taugner R. Intrarenal and intracellular distribution of renin and angiotensin. Kidney Int. 1987;31:S4–S17.
   Web of Science ®Google Scholar
• Razga Z, Nyengaard JR. Up- and down-regulation of angiotensin II AT1A and AT1B receptors in afferent and efferent rat kidney arterioles. J Renin Angiotensin Aldosterone Syst. 2008;9(4):196–201. doi:10.1177/147032030809859219126659
   PubMed Web of Science ®Google Scholar
• Nickenig G, Roling J, Strehlow K, Schnabel P, Bohm M. Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms. Circulation. 1998;98(22):2453–2460. doi:10.1161/01.CIR.98.22.24539832492
   PubMed Web of Science ®Google Scholar
• Nickenig G, Bohm M. Vascular AT(1) receptors in hypertension and metabolic syndrome. Herz Kreislauf. 1998;30:329–334.
   Google Scholar
• Kang JJ, Toma I, Sipos A, Meer EJ, Vargas SL, Peti-Peterdi J. The collecting duct is the major source of prorenin in diabetes. Hypertension. 2008;51(6):1597–1604. doi:10.1161/HYPERTENSIONAHA.107.10726818413493
   PubMed Web of Science ®Google Scholar
• Peti-Peterdi J, Kang JJ, Toma I. Activation of the renal renin-angiotensin system in diabetes–new concepts. Nephrol Dial Transplant. 2008;23(10):3047–3049. doi:10.1093/ndt/gfn37718644796
   PubMed Web of Science ®Google Scholar
• Nguyen G, Contrepas A. Physiology and pharmacology of the (pro)renin receptor. Curr Opin Pharmacol. 2008;8(2):127–132. doi:10.1016/j.coph.2007.12.00918243793
   PubMed Web of Science ®Google Scholar
• Nguyen G, Muller DN. The biology of the (pro)renin receptor. J Am Soc Nephrol. 2010;21(1):18–23. doi:10.1681/ASN.200903030019917780
   PubMed Web of Science ®Google Scholar
• Nguyen G. Renin, (pro)renin and receptor: an update. Clin Sci (Lond). 2011;120(5):169–178. doi:10.1042/CS2010043221087212
   PubMed Web of Science ®Google Scholar
• Terada T, Urushihara M, Saijo T, Nakagawa R, Kagami S. (Pro)renin and (pro)renin receptor expression during kidney development in neonates. Eur J Pediatr. 2017;176(2):183–189. doi:10.1007/s00431-016-2820-927995362
   PubMed Web of Science ®Google Scholar
• Razga Z, Kovacs G, Bódi N, Talapka P, Bagyánszki M. Regulation of (Pro)Renin receptor in renin-positive smooth muscle cells of kidney arterioles in rats with STZ-induced diabetes. Int J Nephrol. 2019;2019:6. doi:10.1155/2019/6971928
   Web of Science ®Google Scholar
• Hayashi K, Wakino S, Sugano N, Ozawa Y, Homma K, Saruta T. Ca 2+ channel subtypes and pharmacology in the kidney. Circ Res. 2007;100(3):342–353. doi:10.1161/01.RES.0000256155.31133.4917307972
   PubMed Web of Science ®Google Scholar
• Beierwaltes WH. The role of calcium in the regulation of renin secretion. Am J Physiol Renal Physiol. 2010;298(1):F1–F11. doi:10.1152/ajprenal.00143.200919640903
   PubMed Web of Science ®Google Scholar
• Wagner C, Kramer BK, Hinder M, Kieninger M, Kurtz A. T-type and L-type calcium channel blockers exert opposite effects on renin secretion and renin gene expression in conscious rats. Br J Pharmacol. 1998;124(3):579–585. doi:10.1038/sj.bjp.07018619647484
   PubMed Web of Science ®Google Scholar
• Taugner R, HACKENTHAL E, Densa M. The Juxtaglomerular Apparatus. Berlin: Springer-Verlag; 1989:25–43.
   Google Scholar
• Christensen JA, Meyer DS, Bohle A. Structure of human juxtaglomerular apparatus - morphometric, light-microscopic study on serial sections. Virchows Arch a Pathol Anat Histopathol. 1975;367(2):83–92. doi:10.1007/BF00430947
   Google Scholar
• Christensen JA, Bohle A. Juxtaglomerular apparatus in normal rat-kidney. Virchows Arch a Pathol Anat Histopathol. 1978;379(2):143–150. doi:10.1007/BF00432483
   Google Scholar
• Christensen JA, Bader H, Bohle A, Meyer DS. Structure of juxtaglomerular apparatus in Addison's-disease, Bartter’s-syndrome, and in Conn’s syndrome - comparative, morphometric, light microscopic study on serial sections. Virchows Arch a Pathol Anat Histopathol. 1976;370(2):103–112. doi:10.1007/BF00430807
   Google Scholar
• Komhoff M, Grone HJ, Klein T, Seyberth HW, Nusing RM. Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function. Am J Physiol. 1997;272:460–468.
   PubMed Web of Science ®Google Scholar
• Castrop H, Schweda F, Schumacher K, Wolf K, Kurtz A. Role of renocortical cyclooxygenase-2 for renal vascular resistance and macula densa control of renin secretion. J Am Soc Nephrol. 2001;12(5):867–874.11316844
   PubMed Web of Science ®Google Scholar
• Castrop H, Klar J, Wagner C, Hocherl K, Kurtz A. General inhibition of renocortical cyclooxygenase-2 expression by the renin-angiotensin system. Am J Physiol Renal Physiol. 2003;284(3):F518–F524. doi:10.1152/ajprenal.00338.200212441308
   PubMed Web of Science ®Google Scholar
• Harris RC, Zhang MZ, Cheng HF. Cyclooxygenase-2 and the renal renin-angiotensin system. Acta Physiol Scand. 2004;181(4):543–547. doi:10.1111/j.1365-201X.2004.01329.x15283769
   PubMedGoogle Scholar
• Ehanire T, Ren L, Bond J, et al. Angiotensin II stimulates canonical TGF-+- signaling pathway through angiotensin type 1 receptor to induce granulation tissue contraction. J Mol Med. 2015;93:289–302.25345602
   PubMed Web of Science ®Google Scholar
• Piera-Velazquez S, Jimenez SA. Endothelial to mesenchymal transition: role in physiology and in the pathogenesis of human diseases. Physiol Rev. 2019;99:1281–1324.30864875
   PubMed Web of Science ®Google Scholar